Dupilumab Dupixent 100mg/0.67mL

Description

Indications for: DUPIXENT
As an add-on maintenance treatment in patients with moderate to severe asthma with an eosinophilic phenotype or with oral corticosteroid dependent asthma.

Limitations of Use:
Not for relief of acute bronchospasm or status asthmaticus.

Adult Dosage:
Can use prefilled pens for patients ?12yrs. Give by SC inj into thigh, abdomen (except around navel), or upper arm; rotate inj sites. Initially 400mg (two 200mg inj at different sites) followed by 200mg every 2 weeks; or, initially 600mg (two 300mg inj at different sites) followed by 300mg every 2 weeks. For those with oral corticosteroid-dependent asthma or with co-morbid moderate to severe atopic dermatitis or co-morbid chronic rhinosinusitis with nasal polyposis: initially 600mg (two 300mg inj at different sites) followed by 300mg every 2 weeks.